Beijing Kawin Technology Share-holding Co Ltd
SSE:688687

Watchlist Manager
Beijing Kawin Technology Share-holding Co Ltd Logo
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Watchlist
Price: 22.5 CNY -1.14% Market Closed
Market Cap: 3.8B CNY

Beijing Kawin Technology Share-holding Co Ltd
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Beijing Kawin Technology Share-holding Co Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Beijing Kawin Technology Share-holding Co Ltd
SSE:688687
Cash from Operating Activities
¥104.3m
CAGR 3-Years
-4%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash from Operating Activities
-¥1.3B
CAGR 3-Years
47%
CAGR 5-Years
26%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Cash from Operating Activities
¥1.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
RemeGen Co Ltd
SSE:688331
Cash from Operating Activities
-¥1.1B
CAGR 3-Years
N/A
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Cash from Operating Activities
-¥527.6m
CAGR 3-Years
19%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
S
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Cash from Operating Activities
-¥429.8m
CAGR 3-Years
4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Beijing Kawin Technology Share-holding Co Ltd
Glance View

Market Cap
3.8B CNY
Industry
Biotechnology

Beijing Kawin Technology Share-Holding Co., Ltd. provides biotechnology treatment solutions and medicines. The company is headquartered in Beijing, Beijing and currently employs 647 full-time employees. The company went IPO on 2021-02-08. The firm's recombinant human interferon α2b and compound glycyrrhizin drugs are applied to treat viral diseases. The firm mainly distributes its products within domestic market.

Intrinsic Value
21.39 CNY
Overvaluation 5%
Intrinsic Value
Price

See Also

What is Beijing Kawin Technology Share-holding Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
104.3m CNY

Based on the financial report for Dec 31, 2024, Beijing Kawin Technology Share-holding Co Ltd's Cash from Operating Activities amounts to 104.3m CNY.

What is Beijing Kawin Technology Share-holding Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
0%

Over the last year, the Cash from Operating Activities growth was -18%. The average annual Cash from Operating Activities growth rates for Beijing Kawin Technology Share-holding Co Ltd have been -4% over the past three years .

Back to Top